CMV reactivation after allogeneic HCT is associated with a reduced risk of relapse in acute lymphoblastic leukemia

Cytomegalovirus reactivation (CMVR) after allogeneic hematopoietic cell transplantation (HCT) is a frequent complication related to survival outcomes; however, its impact on relapse remains unclear, especially in acute lymphoblastic leukemia (ALL). In this nationwide retrospective study, we included...

Descripción completa

Detalles Bibliográficos
Autores principales: Akahoshi, Yu, Nakasone, Hideki, Takenaka, Katsuto, Yamasaki, Satoshi, Nakamura, Momoko, Doki, Noriko, Tanaka, Masatsugu, Ozawa, Yukiyasu, Uchida, Naoyuki, Ara, Takahide, Nakamae, Hirohisa, Ota, Shuichi, Onizuka, Makoto, Yano, Shingo, Tanaka, Junji, Fukuda, Takahiro, Kanda, Yoshinobu, Atsuta, Yoshiko, Kako, Shinichi, Yanada, Masamitsu, Arai, Yasuyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333743/
https://www.ncbi.nlm.nih.gov/pubmed/36661335
http://dx.doi.org/10.1182/bloodadvances.2022009376

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333743/
https://www.ncbi.nlm.nih.gov/pubmed/36661335
http://dx.doi.org/10.1182/bloodadvances.2022009376

Ejemplares similares